Log in or Sign up for Free to view tailored content for your specialty!
Scleroderma News
Cyclophosphamide treatment for systemic sclerosis linked to lower ovarian reserve in women
NASHVILLE, Tenn. — In women with systemic sclerosis, cyclophosphamide therapy negatively correlated with ovarian reserve, according to a presenter at the CHEST Annual Meeting.
Perceived cognitive dysfunction more likely in patients with SSc who have greater fatigue
Among patients with systemic sclerosis, those on work disability and who experience greater levels of fatigue are more likely to perceive cognitive dysfunction, according to data published in Arthritis Care & Research.
Log in or Sign up for Free to view tailored content for your specialty!
Nintedanib maintains safety, efficacy long-term in patients with SSc-associated ILD
Nintedanib maintains its safety and efficacy for up to 3 years in patients with systemic sclerosis-associated interstitial lung disease, according to data published the Annals of the Rheumatic Diseases.
FDA grants fast-track designation for efzofitimod in systemic sclerosis-associated ILD
The FDA has granted fast-track designation for efzofitimod, a potential first-in-class immunomodulator, in the treatment of systemic sclerosis-associated interstitial lung disease, according to a press release from the drug’s manufacturer.
ILD Day: Recent updates in treatment, management of interstitial lung disease
Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases.
Patients with autoimmune disease receiving ICI exhibit better survival vs. controls
Although they exhibit a greater risk for severe immune-related adverse effects, patients with preexisting autoimmune disease receiving immune checkpoint inhibitors for melanoma had better 2-year survival than controls, according to data.
Risk for systemic autoimmune rheumatic diseases higher in areas with air pollution
Exposure to fine particulate matter — specifically particles 2.5 µm or less in diameter, or PM2.5 — in the air signals a higher risk for systemic autoimmune rheumatic diseases, according to data published in Arthritis Research & Therapy.
Medical cannabis growing in acceptance, improves pain in several rheumatic diseases
ORLANDO — Medical cannabis is growing in acceptance and has benefits for managing pain in patients with rheumatic diseases, but more research is required, a presenter said at the 2022 Rheumatology Nurses Society Conference.
‘Bad for patients’: Rheumatologists express dismay over Roe v. Wade reversal
In the wake of the Supreme Court’s decision overturning Roe v. Wade, rheumatologists and rheumatology associations are voicing concern over what the loss of federal abortion protections could mean for patients.
Risk for adverse pregnancy outcomes greater in systemic sclerosis than lupus
Pregnant patients with systemic sclerosis demonstrate a higher risk for adverse pregnancy outcomes, including preterm delivery, than those with lupus and healthy controls, according to data published in Arthritis Research & Therapy.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read